The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are ...

At its current valuation, DexCom stock is the opposite of a bargain. Even after its big drop over the summer, it would still be a risky stock to buy now. Those who are interested would probably do ...

On September 26, the U.S. Court of Appeals for the Second Circuit issued a ruling in Abbott Laboratories v. H&H Wholesale ...

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Some people who use a Freestyle Libre 3 glucose sensor are facing delays getting their prescriptions filled. Abbott spokesperson Lindsy Delco said the delays are driven by strong demand for the Libre ...

So, while you should always follow the fundamentals of healthy living – like exercising and eating a balanced diet – ...

In 2008 Abbott introduced a revolutionary new device, FreeStyle Navigator, designed to improve the lives of the world’s more than 500 million diabetes patients by offering continuous glucose ...

Further, Abbott’s Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre. In a relatively short ...

Nearly half of all people with Type 2 diabetes are people aged 65 or older. Fortunately, innovative technologies – like continuous glucose monitors (CGM) have made managing diabetes easier for ...

Abbott ABT is facing a challenging business environment globally. Unfavorable foreign exchange impact continues to impede growth. The stock carries a Zacks Rank #4 (Sell) currently. A challenging ...